Sanofi India Q2 net dips 14 per cent at Rs 73 crore

Published On 2017-07-23 04:23 GMT   |   Update On 2017-07-23 04:23 GMT

New Delhi: Drug firm Sanofi India reported a 14.40 per cent dip in its net profit to Rs 73.7 crore for the second quarter ended June.


The company had posted a net profit of Rs 86.1 crore in the corresponding period of the previous fiscal, Sanofi India said in a BSE filing.


Total revenue from operations of the company stood at Rs 600.6 crore for the quarter under consideration as against Rs 620.2 crore for the same period a year ago.


"Gross sales and profit before tax for the quarter and half year ended June 30, 2017 were impacted due to down stocking in trade channels in anticipation of the GST regime", Sanofi India said.


Appropriate provisions have been made to prepare for company's transition to new GST system, it added.


In a separate filing, Sanofi India said that its board has declared an interim dividend of Rs 18 per equity share of Rs 10 each for the financial year ending December 31, 2017.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News